Prominent Perspective on Existing Biological Hallmarks of Alzheimer's Disease

被引：1

作者：

Singh, Namrata ^{[1
,2
]}

Sharma, Srishti ^{[3
]}

Ghosh, Kallol K. ^{[3
]}

Gupta, Bhanushree ^{[4
]}

Kuca, Kamil ^{[2
,5
]}

机构：

[1] DY Patil Univ, Ramrao Adik Inst Technol, Dept Engn Sci, Navi Mumbai 400706, India

[2] Univ Hradec Kralove, Fac Sci, Dept Chem, Rokitanskeho 62, Hradec Kralove 50003, Czech Republic

[3] Pt Ravishankar Shukla Univ, Sch Studies Chem, Raipur 492010, Chhattisgarh, India

[4] Pt Ravishankar Shukla Univ, Ctr Basic Sci, Raipur 492010, Chhattisgarh, India

[5] Univ Hradec Kralove, Res Inst Biomed Sci, Antonina Dvoraka 451-1, Hradec Kralove 50002, Czech Republic

来源：

CURRENT TOPICS IN MEDICINAL CHEMISTRY | 2024年 / 24卷 / 13期

关键词：

Alzheimer's disease; Biomarkers; beta-amyloid peptide; Tau protein; Neurodegenerative diseases; Diagnosis; MILD COGNITIVE IMPAIRMENT; CEREBROSPINAL-FLUID; CSF BIOMARKERS; AMYLOID-BETA; BLOOD BIOMARKERS; TAU; DIAGNOSIS; PATHOLOGY; MARKER;

D O I：

10.2174/0115680266292514240404040341

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Biomarkers are the most significant diagnosis tools tending towards unique approaches and solutions for the prevention and cure of Alzheimer's Disease (AD). The current report provides a clear perception of the concept of various biomarkers and their prominent features through analysis to provide a possible solution for the inhibition of events in AD. Scientists around the world truly believe that crucial hallmarks can serve as critical tools in the early diagnosis, cure, and prevention, as well as the future of medicine. The awareness and understanding of such biomarkers would provide solutions to the puzzled mechanism of this neuronal disorder. Some of the argued biomarkers in the present article are still in an experimental phase as they need to undergo specific clinical trials before they can be considered for treatment.

引用

页码：1120 / 1133

页数：14

共 108 条

[71]

Olsson B, 2016, LANCET NEUROL, V15, P673, DOI [10.1016/S1474-4422(16)00070-3, 10.1016/s1474-4422(16)00070-3]

[72] Performance of Fully Automated Plasma Assays as Screening Tests for Alzheimer Disease-Related β-Amyloid Status [J].

Palmqvist, Sebastian ;

Janelidze, Shorena ;

Stomrud, Erik ;

Zetterberg, Henrik ;

Karl, Johann ;

Zink, Katharina ;

Bittner, Tobias ;

Mattsson, Niklas ;

Eichenlaub, Udo ;

Blennow, Kaj ;

Hansson, Oskar .

JAMA NEUROLOGY, 2019, 76 (09) :1060-1069

[73] CSF Biomarkers in the Early Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease [J].

Papaliagkas, Vasileios ;

Kalinderi, Kallirhoe ;

Vareltzis, Patroklos ;

Moraitou, Despoina ;

Papamitsou, Theodora ;

Chatzidimitriou, Maria .

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (10)

[74]

Patel S, 2012, FLUIDS BARRIERS CNS, V9, DOI 10.1186/2045-8118-9-7

[75] Plasma GFAP is an early marker of amyloid-β but not tau pathology in Alzheimer's disease [J].

Pereira, Joana B. ;

Janelidze, Shorena ;

Smith, Ruben ;

Mattsson-Carlgren, Niklas ;

Palmqvist, Sebastian ;

Teunissen, Charlotte E. ;

Zetterberg, Henrik ;

Stomrud, Erik ;

Ashton, Nicholas J. ;

Blennow, Kaj ;

Hansson, Oskar .

BRAIN, 2021, 144 :3505-3516

[76] Soluble amyloid precursor protein β as blood-based biomarker of Alzheimer's disease [J].

Perneczky, R. ;

Guo, L-H ;

Kagerbauer, S. M. ;

Werle, L. ;

Kurz, A. ;

Martin, J. ;

Alexopoulos, P. .

TRANSLATIONAL PSYCHIATRY, 2013, 3 :e227-e227

[77] Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer's disease [J].

Preische, Oliver ;

Schultz, Stephanie A. ;

Apel, Anja ;

Kuhle, Jens ;

Kaeser, Stephan A. ;

Barro, Christian ;

Graeber, Susanne ;

Kuder-Buletta, Elke ;

LaFougere, Christian ;

Laske, Christoph ;

Voeglein, Jonathan ;

Levin, Johannes ;

Masters, Colin L. ;

Martins, Ralph ;

Schofield, Peter R. ;

Rossor, Martin N. ;

Graff-Radford, Neill R. ;

Salloway, Stephen ;

Ghetti, Bernardino ;

Ringman, John M. ;

Noble, James M. ;

Chhatwal, Jasmeer ;

Goate, Alison M. ;

Benzinger, Tammie L. S. ;

Morris, John C. ;

Bateman, Randall J. ;

Wang, Guoqiao ;

Fagan, Anne M. ;

McDade, Eric M. ;

Gordon, Brian A. ;

Jucker, Mathias ;

Allegri, Ricardo ;

Amtashar, Fatima ;

Bateman, Randall ;

Benzinger, Tammie ;

Berman, Sarah ;

Bodge, Courtney ;

Brandon, Susan ;

Brooks, William ;

Buck, Jill ;

Buckles, Virginia ;

Chea, Sochenda ;

Chhatwal, Jasmeer ;

Chrem, Patricio ;

Chui, Helena ;

Cinco, Jake ;

Clifford, Jack ;

Cruchaga, Carlos ;

D'Mello, Mirelle ;

Donahue, Tamara .

NATURE MEDICINE, 2019, 25 (02) :277-+

[78]

Reitz C, 2011, NAT REV NEUROL, V7, P137, DOI [10.1038/nrneurol.2011.2, 10.1101/cshperspect.a006239]

[79] Misfolding of Amyloidogenic Proteins and Their Interactions with Membranes [J].

Relini, Annalisa ;

Marano, Nadia ;

Gliozzi, Alessandra .

BIOMOLECULES, 2014, 4 (01) :20-55

[80] Assessment of suberoylanilide hydroxamic acid on a Alzheimer?s disease model induced by ?-amyloid(1-42) in aged female mice: Neuromodulatory and epigenetic effect [J].

Rocha, Kellen Mariane Athaide ;

Machado, Franciele Romero ;

Giacomeli, Renata ;

Boeira, Silvana Peterini ;

Jesse, Cristiano Ricardo ;

de Gomes, Marcelo Gomes .

CHEMICO-BIOLOGICAL INTERACTIONS, 2023, 375

← 2 3 4 5 6 7 8 9 10 11 →